Fabricio Aline S C, Rae Giles A, Zampronio Aleksander R, D'Orléans-Juste Pedro, Souza Glória E P
Laboratório de Farmacologia, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Av. do Café, s/n-Campus USP 14040-903 Ribeirão Preto, SP, Brazil.
Am J Physiol Regul Integr Comp Physiol. 2006 Jan;290(1):R164-71. doi: 10.1152/ajpregu.00337.2005. Epub 2005 Aug 25.
Blockade of central endothelin ET(B) receptors inhibits fever induced by LPS in conscious rats. The contribution of ET(B) receptor-mediated mechanisms to fever triggered by intracerebroventricular IL-6, PGE2, PGF(2alpha), corticotropin-releasing factor (CRF), and preformed pyrogenic factor derived from LPS-stimulated macrophages (PFPF) was examined. The influence of natural IL-1 receptor antagonist or soluble TNF receptor I on endothelin (ET)-1-induced fever was also assessed. The selective ET(B) receptor antagonist BQ-788 (3 pmol icv) abolished fever induced by intracerebroventricular ET-1 (1 pmol) or PFPF (200 ng) and reduced that caused by ICV CRF (1 nmol) but not by IL-6 (14.6 pmol), PGE2 (1.4 nmol), or PGF(2alpha) (2 nmol). CRF-induced fever was also attenuated by bosentan (dual ET(A)/ET(B) receptor antagonist; 10 mg/kg iv) but unaffected by BQ-123 (selective ET(A) receptor antagonist; 3 pmol icv). alpha-Helical CRF(9-41) (dual CRF1/CRF2 receptor antagonist; 6.5 nmol icv) attenuated fever induced by CRF but not by ET-1. Human IL-1 receptor antagonist (9.1 pmol) markedly reduced fever to IL-1beta (180 fmol) or ET-1 and attenuated that caused by PFPF or CRF. Murine soluble TNF receptor I (23.8 pmol) reduced fever to TNF-alpha (14.7 pmol) but not to ET-1. The results of the present study suggest that PFPF and CRF recruit the brain ET system to cause ET(B) receptor-mediated IL-1-dependent fever.
阻断中枢内皮素ET(B)受体可抑制清醒大鼠由脂多糖诱导的发热。研究了ET(B)受体介导的机制对脑室内注射白细胞介素-6(IL-6)、前列腺素E2(PGE2)、前列腺素F2α(PGF(2α))、促肾上腺皮质激素释放因子(CRF)以及脂多糖刺激的巨噬细胞产生的预成型致热因子(PFPF)引发发热的作用。还评估了天然白细胞介素-1受体拮抗剂或可溶性肿瘤坏死因子受体I对内皮素(ET)-1诱导发热的影响。选择性ET(B)受体拮抗剂BQ-788(脑室内注射3皮摩尔)可消除脑室内注射ET-1(1皮摩尔)或PFPF(200纳克)诱导的发热,并减轻脑室内注射CRF(1纳摩尔)引起的发热,但对脑室内注射IL-6(14.6皮摩尔)、PGE2(1.4纳摩尔)或PGF(2α)(2纳摩尔)引起的发热无影响。波生坦(双重ET(A)/ET(B)受体拮抗剂;静脉注射10毫克/千克)也可减轻CRF诱导的发热,但BQ-123(选择性ET(A)受体拮抗剂;脑室内注射3皮摩尔)对其无影响。α-螺旋CRF(9 - 41)(双重CRF1/CRF2受体拮抗剂;脑室内注射6.5纳摩尔)可减轻CRF诱导的发热,但对ET-1诱导的发热无影响。人白细胞介素-1受体拮抗剂(9.1皮摩尔)可显著降低对IL-1β(180飞摩尔)或ET-1的发热反应,并减轻PFPF或CRF引起的发热。小鼠可溶性肿瘤坏死因子受体I(23.8皮摩尔)可降低对肿瘤坏死因子-α(14.7皮摩尔)的发热反应,但对ET-1引起的发热无影响。本研究结果表明,PFPF和CRF募集脑ET系统导致ET(B)受体介导的白细胞介素-依赖型发热。